The Journal Pulse - Hematologic Oncology copertina

The Journal Pulse - Hematologic Oncology

The Journal Pulse - Hematologic Oncology

Di: The Journal Pulse Team
Ascolta gratuitamente

Offerte di stagione | 0,99 €/mese per i primi 3 mesi

A seguire 9,99 €/mese – si applicano condizioni. Puoi disdire mensilmente.
Weekly discussions on the latest evidence in hematologic oncology - from landmark trials to practice-changing papers.The Journal Pulse Team Disturbo fisico e malattia Igiene e vita sana
  • Bortezomib in T-Cell ALL: Did Adding a Proteasome Inhibitor Move the Needle for Kids with the Hardest Leukemia to Treat?
    Jul 15 2026

    One landmark clinical paper, dissected every week.

    pulsosaudepodcast@gmail.com


    ARTICLE REFERENCE:

    • Children's Oncology Group Trial AALL1231: A Phase III Clinical Trial Testing Bortezomib in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia and Lymphoma
    • Authors: Teachey DT, Devidas M, Wood BL et al.
    • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    • https://doi.org/10.1200/JCO.21.02678
    Mostra di più Mostra meno
    25 min
  • High-Dose Cytarabine and Vorinostat in AML: When Intensification Meets Epigenetics
    Jul 8 2026

    One landmark clinical paper, dissected every week.

    pulsosaudepodcast@gmail.com


    ARTICLE REFERENCE:

    • A randomized phase III study of standard versus high-dose cytarabine with or without vorinostat for AML
    • Authors: Garcia-Manero G, Podoltsev NA, Othus M et al.
    • Journal: Leukemia
    • https://doi.org/10.1038/s41375-023-02073-x
    Mostra di più Mostra meno
    24 min
  • CANOVA Trial: Venetoclax-Dexamethasone vs Pomalidomide-Dexamethasone in t(11;14) Relapsed/Refractory Multiple Myeloma
    Jul 1 2026

    One landmark clinical paper, dissected every week.

    pulsosaudepodcast@gmail.com


    ARTICLE REFERENCE:

    • Venetoclax-Dexamethasone Versus Pomalidomide-Dexamethasone in t(11;14)-Positive Relapsed/Refractory Multiple Myeloma: Primary Results of the Randomized, Phase III CANOVA Study
    • Authors: Popat R, Beksac M, Dimopoulos MA et al.
    • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    • https://doi.org/10.1200/JCO-25-00924
    Mostra di più Mostra meno
    27 min
adbl_web_anon_alc_button_suppression_t1
Ancora nessuna recensione